Partner Headlines - POZN

  1. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! ...

    Benzinga
  2. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga
  3. Morning Market Losers

    Benzinga
  4. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  5. POZEN Receives CRL From FDA

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. Pozen Submits Final Study Report for PA8140/PA32540 Phase 1 Study ...

    Benzinga
  9. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  10. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  11. Morning Market Losers

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Benzinga's Top Downgrades

    Benzinga
  14. POZEN New PA8140/PA32540 PDUFA Date is April 25, 2014

    Benzinga
  15. POZEN Announces December 31, 2013 as Ex-Dividend Date for Previously ...

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. POZEN Announces Special Cash Distribution of $1.75/Share

    Benzinga
  18. Horizon to Acquire US Rights for VIMOVO from Pozen

    Benzinga
  19. Benzinga's Top Pre-Market Gainers

    Benzinga
  20. Stocks To Watch For September 5, 2013

    Benzinga
  21. SANOFI

    IBD
  22. Sanofi, Pozen Announce Exclusive License Deal for Commercialization ...

    Benzinga
  23. Pozen Inc. Reports Operating Results (10-Q)

    GuruFocus
  24. UPDATE: Ascendiant Capital Markets Initiates POZEN at Buy; Future ...

    Benzinga
  25. POZEN Announces PA32540 Provides Superior Antiplatlet Effects ...

    Benzinga
  26. POZEN Provides Positive Update on Its PA Program and Results ...

    Benzinga
  27. POZEN Receives Patent on PA Products for Treatment of Cardiovascular ...

    Benzinga
  28. Celgene, Bed Bath & Beyond Among Stocks Gapping Down Thursday

    FoxBusiness
  29. Morning Market Losers

    Benzinga
  30. POZEN Says FDA Does Not Agree That BioEquivalence Was Demonstrated

    Benzinga
  31. POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH ...

    Benzinga
Trading Center